Livmarli
NDC 79378-220, maralixibat chloride, tablet, from Mirum Pharmaceuticals Inc..
- Product NDC
- 79378-220
- Status
- Listed
- Labeler
- Mirum Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219485
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/79378-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MARALIXIBAT CHLORIDE20 mg/1
Pharmacologic classes
Ileal Bile Acid Transporter Inhibitor [EPC]; Ileal Bile Acid Transporter Inhibitors [MoA]; Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 79378-220-30 | 79378022030 | 1 BOTTLE in 1 CARTON (79378-220-30) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/64000394-1ef6-4e76-8ba8-11f25ba1b167
Use it
Look up 79378-220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/79378-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 79378-220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.